Gyros has announced that GE Healthcare Life Sciences has become the sole distributor for its nanolitre-scale immunoassay platform to biopharmaceutical and vaccine manufacturers in Japan.
The Gyros platform is used by biopharmaceutical companies and their service providers to improve productivity and efficiency during the development of biotherapeutics and vaccines, boosting time-critical workflows and helping to meet regulatory demands.
